Monday, 29 June 2020

Gilead Science releases pricing plan for COVID-19 drug Remdesivir - One America News Network

  1. Gilead Science releases pricing plan for COVID-19 drug Remdesivir  One America News Network
  2. Gilead sets U.S. price for Covid-19 drug remdesivir at $3120 for typical treatment  CNBC Television
  3. Gilead prices COVID-19 drug remdesivir at $2,340 per patient in developed nations  Yahoo Finance
  4. Gilead Sets a Good-Enough Bar With Covid-Treatment Price  Bloomberg
  5. Dr. Marc Siegel: Coronavirus defense — as numbers rise, promising drug Remdesivir cleared for use  Fox News
  6. View Full Coverage on Google News
on

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)